Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-KAD in Age-Related Nuclear Cataracts
NCT00825721Phase 2Unknown
- Sponsor
- Chakshu Research, Inc.
- Start
- Nov 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of ethylenediaminetetraacetic acid in nuclear cataract (NS) (4 arms), sponsored by Chakshu Research, Inc. Primary endpoint: Best-corrected visual acuity at 360 days. Status: unknown.
02
Drugs
ethylenediaminetetraacetic acid
03
Conditions
nuclear cataract (NS)
Beyond the preview
Go deeper on NCT00825721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00825721.